Механизмы плохой переносимости физической нагрузки у больных сердечной недостаточностью с сохраненной фракцией выброса. Часть II: Роль правых камер сердца, сосудов и скелетной мускулатуры

Основным клиническим проявлением сердечной недостаточности с сохраненной ФВ (СНсФВ) является плохая переносимость физической нагрузки. Помимо дисфункции левых камер сердца, которая была представлена в первой части настоящего обзора, в плохой переносимости нагрузки у таких больных участвуют и многие другие нарушения: со стороны правых камер сердца, сосудистой системы и скелетной мускулатуры. Во второй части настоящего обзора представлены механизмы развития этих нарушений, а также возможные способы их коррекции. 

1. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT et al. Systolic and Diastolic Heart Failure in the Community. JAMA. 2006;296(18):2209–16. DOI: 10.1001/jama.296.18.2209

2. Borlaug BA. The pathophysiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology. 2014;11(9):507–15. DOI: 10.1038/nrcardio.2014.83

3. Lam CSP, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology. 2009;53(13):1119–26. DOI: 10.1016/j.jacc.2008.11.051

4. Guazzi M, Borlaug BA. Pulmonary Hypertension Due to Left Heart Disease. Circulation. 2012;126(8):975–90. DOI: 10.1161/CIRCULATIONAHA.111.085761

5. Borlaug BA, Nishimura RA, Sorajja P, Lam CSP, Redfield MM. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure with Preserved Ejection Fraction. Circulation: Heart Failure. 2010;3(5):588–95. DOI: 10.1161/CIRCHEARTFAILURE.109.930701

6. Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA. Effects of Vasodilation in Heart Failure with Preserved or Reduced Ejection Fraction. Journal of the American College of Cardiology. 2012;59(5):442–51. DOI: 10.1016/j.jacc.2011.09.062

7. Tribouilloy CM, Enriquez-Sarano M, Rossi A, Tajik AJ, Seward JB. Determinants of the pulmonary artery pressure rise in left ventricular dysfunction. Cardiologia (Rome, Italy). 1997;42(10):1051–8. PMID: 9534280

8. Freed BH, Daruwalla V, Cheng JY, Aguilar FG, Beussink L, Choi A et al. Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure with Preserved Ejection Fraction: Importance of Left Atrial Strain. Circulation: Cardiovascular Imaging. 2016;9(3):e003754. DOI: 10.1161/CIRCIMAGING.115.003754

9. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. European Respiratory Journal. 2009;34(4):888–94. DOI: 10.1183/09031936.00145608

10. Kuehne T. Magnetic Resonance Imaging Analysis of Right Ventricular Pressure-Volume Loops: In Vivo Validation and Clinical Application in Patients with Pulmonary Hypertension. Circulation. 2004;110(14):2010–6. DOI: 10.1161/01.CIR.0000143138.02493.DD

11. Katz DH, Burns JA, Aguilar FG, Beussink L, Shah SJ. Albuminuria Is Independently Associated with Cardiac Remodeling, Abnormal Right and Left Ventricular Function, and Worse Outcomes in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 2014;2(6):586– 96. DOI: 10.1016/j.jchf.2014.05.016

12. Cuspidi C, Valerio C, Sala C, Negri F, Esposito A, Masaidi M et al. Metabolic syndrome and biventricular hypertrophy in essential hypertension. Journal of Human Hypertension. 2009;23(3):168–75. DOI: 10.1038/jhh.2008.119

13. Tadic M, Ivanovic B, Grozdic I. Metabolic Syndrome Impacts the Right Ventricle: True or False? Metabolic Syndrome and Right Ventricle. Echocardiography. 2011;28(5):530–8. DOI: 10.1111/j.15408175.2011.01390.x

14. Hilde JM, Skjorten I, Grotta OJ, Hansteen V, Melsom MN, Hisdal J et al. Right Ventricular Dysfunction and Remodeling in Chronic Obstructive Pulmonary Disease Without Pulmonary Hypertension. Journal of the American College of Cardiology. 2013;62(12):1103–11. DOI: 10.1016/j.jacc.2013.04.091

15. Chahal H, McClelland RL, Tandri H, Jain A, Turkbey EB, Hundley WG et al. Obesity and Right Ventricular Structure and Function. Chest. 2012;141(2):388–95. DOI: 10.1378/chest.11-0172

16. Wong CY, O’Moore-Sullivan T, Leano R, Hukins C, Jenkins C, Marwick TH. Association of Subclinical Right Ventricular Dysfunction with Obesity. Journal of the American College of Cardiology. 2006;47(3):611–6. DOI: 10.1016/j.jacc.2005.11.015

17. Melenovsky V, Hwang S-J, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. European Heart Journal. 2014;35(48):3452–62. DOI: 10.1093/eurheartj/ehu193

18. Borlaug BA, Kane GC, Melenovsky V, Olson TP. Abnormal right ventricularpulmonary artery coupling with exercise in heart failure with preserved ejection fraction. European Heart Journal. 2016;37(43):3293– 302. DOI: 10.1093/eurheartj/ehw241

19. Andersen MJ, Hwang S-J, Kane GC, Melenovsky V, Olson TP, Fetterly K et al. Enhanced Pulmonary Vasodilator Reserve and Abnormal Right Ventricular: Pulmonary Artery Coupling In Heart Failure With Preserved Ejection Fraction. Circulation: Heart Failure. 2015;8(3):542–50. DOI: 10.1161/CIRCHEARTFAILURE.114.002114

20. Reddy YNV, Obokata M, Koepp KE, Egbe AC, Wiley B, Borlaug BA. The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial. Circulation Research. 2019;124(2):306–14. DOI: 10.1161/CIRCRESAHA.118.313832

21. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR et al. Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading. Circulation. 2012;125(2):289–97. DOI: 10.1161/CIRCULATIONAHA.111.051540

22. Ovchinnikov AG, Potekhina AV, Gavryushina SV, Ageev FT. P2138. Sildenafil improves functional capacity and exercise hemodynamics in patients with heart failure with preserved left ventricular ejection fraction and predominantly combined preand post-capillary pulmonary hypertension. European Journal of Heart Failure. 2018;20(Suppl 1):567. DOI: 10.1002/ejhf.1197

23. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. Journal of the American College of Cardiology. 1999;34(6):1802–6. PMID: 10577573

24. Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH et al. Cardiovascular Features of Heart Failure with Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community. Journal of the American College of Cardiology. 2007;49(2):198–207. DOI: 10.1016/j.jacc.2006.08.050

25. Atherton JJ, Moore TD, Lele SS, Thomson HL, Galbraith AJ, Belenkie I et al. Diastolic ventricular interaction in chronic heart failure. The Lancet. 1997;349(9067):1720–4. DOI: 10.1016/S0140-6736(96)05109-4

26. Janicki JS. Influence of the pericardium and ventricular interdependence on left ventricular diastolic and systolic function in patients with heart failure. Circulation. 1990;81(2 Suppl): III15-20. PMID: 2297880

27. Borlaug BA, Olson TP, Lam CSP, Flood KS, Lerman A, Johnson BD et al. Global Cardiovascular Reserve Dysfunction in Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology. 2010;56(11):845–54. DOI: 10.1016/j.jacc.2010.03.077

28. Dauterman K. Contribution of External Forces to Left Ventricular Diastolic Pressure: Implications for the Clinical Use of the Starling Law. Annals of Internal Medicine. 1995;122(10):737. DOI: 10.7326/00034819-122-10-199505150-00001

29. Borlaug BA, Carter RE, Melenovsky V, De Simone CV, Gaba P, Killu A et al. Percutaneous Pericardial Resection: A Novel Potential Treatment for Heart Failure with Preserved Ejection Fraction. Circulation: Heart Failure. 2017;10(4):e003612. DOI: 10.1161/CIRCHEARTFAILURE.116.003612

30. Borlaug BA, Schaff HV, Pochettino A, Pedrotty DM, Asirvatham SJ, Abel MD et al. Pericardiotomy Enhances Left Ventricular Diastolic Reserve with Volume Loading in Humans: Implications for the Surgical Management of Heart Failure with Preserved Ejection Fraction. Circulation. 2018;138(20):2295–7. DOI: 10.1161/CIRCULATIONAHA.118.036006

31. Guazzi M, Vicenzi M, Arena R, Guazzi MD. Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study. Circulation. 2011;124(2):164–74. DOI: 10.1161/CIRCULATIONAHA.110.983866

32. Hacobian M, Cohen MC, Atherton D, Wirth JA. Right Ventricular Exercise Echocardiographic Predictors of Worsened Clinical Status in Patients with Pulmonary Arterial Hypertension. A4996. American Thoracic Society 2011 International Conference, May 13-18, 2011. Denver Colorado. DOI: 10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A4996. [Av. at: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A4996 ]

33. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309(12):1268–77. DOI: 10.1001/jama.2013.2024

34. Hoendermis ES, Liu LCY, Hummel YM, van der Meer P, de Boer RA, Berger RMF et al. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. European Heart Journal. 2015;36(38):2565–73. DOI: 10.1093/eurheartj/ehv336

35. Olson TP, Johnson BD, Borlaug BA. Impaired Pulmonary Diffusion in Heart Failure with Preserved Ejection Fraction. JACC: Heart Failure. 2016;4(6):490–8. DOI: 10.1016/j.jchf.2016.03.001

36. Melenovsky V, Andersen MJ, Andress K, Reddy YN, Borlaug BA. Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications: Congestion and pulmonary haemodynamics in HF. European Journal of Heart Failure. 2015;17(11):1161–71. DOI: 10.1002/ejhf.417

37. Hoeper MM, Meyer K, Rademacher J, Fuge J, Welte T, Olsson KM. Diffusion Capacity and Mortality in Patients with Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction. JACC: Heart Failure. 2016;4(6):441–9. DOI: 10.1016/j.jchf.2015.12.016

38. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC et al. Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients with Heart Failure and a Preserved Ejection Fraction. Circulation. 2006;114(20):2138–47. DOI: 10.1161/CIRCULATIONAHA.106.632745

39. Abudiab MM, Redfield MM, Melenovsky V, Olson TP, Kass DA, Johnson BD et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. European Journal of Heart Failure. 2013;15(7):776–85. DOI: 10.1093/eurjhf/hft026

40. Ennezat PV, Lefetz Y, Marechaux S, Six-Carpentier M, Deklunder G, Montaigne D et al. Left Ventricular Abnormal Response During Dynamic Exercise in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction at Rest. Journal of Cardiac Failure. 2008;14(6):475–80. DOI: 10.1016/j.cardfail.2008.02.012

41. Tartiere-Kesri L, Tartiere J-M, Logeart D, Beauvais F, Cohen Solal A. Increased Proximal Arterial Stiffness and Cardiac Response with Moderate Exercise in Patients with Heart Failure and Preserved Ejection Fraction. Journal of the American College of Cardiology. 2012;59(5):455–61. DOI: 10.1016/j.jacc.2011.10.873

42. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME et al. Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients with Systolic Heart Failure. Circulation. 2006;115(1):59–66. DOI: 10.1161/CIRCULATIONAHA.106.626226

43. Melenovsky V, Al-Hiti H, Kazdova L, Jabor A, Syrovatka P, Malek I et al. Transpulmonary B-Type Natriuretic Peptide Uptake and Cyclic Guanosine Monophosphate Release in Heart Failure and Pulmonary Hypertension. Journal of the American College of Cardiology. 2009;54(7):595–600. DOI: 10.1016/j.jacc.2009.05.021

44. Mahmud A, Hennessy M, Feely J. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men. Journal of Human Hypertension. 2001;15(10):707–13. DOI: 10.1038/sj.jhh.1001244

45. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined Ventricular Systolic and Arterial Stiffening in Patients with Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations. Circulation. 2003;107(5):714–20. DOI: 10.1161/01.CIR.0000048123.22359.A0

46. Kitzman DW, Herrington DM, Brubaker PH, Moore JB, Eggebeen J, Haykowsky MJ. Carotid Arterial Stiffness and Its Relationship to Exercise Intolerance in Older Patients with Heart Failure and Preserved Ejection Fraction. Hypertension. 2013;61(1):112–9. DOI: 10.1161/HYPERTENSIONAHA.111.00163

47. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. Journal of the American College of Cardiology. 2001;38(3):796–802. PMID: 11527636

48. Reddy YNV, Andersen MJ, Obokata M, Koepp KE, Kane GC, Melenovsky V et al. Arterial Stiffening with Exercise in Patients with Heart Failure and Preserved Ejection Fraction. Journal of the American College of Cardiology. 2017;70(2):136–48. DOI: 10.1016/j.jacc.2017.05.029

49. Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. Journal of Applied Physiology. 2008;105(4):1342–51. DOI: 10.1152/japplphysiol.90600.2008

50. Leite-Moreira AF, Correia-Pinto J. Load as an acute determinant of enddiastolic pressure-volume relation. American Journal of PhysiologyHeart and Circulatory Physiology. 2001;280(1):H51–9. DOI: 10.1152/ajpheart.2001.280.1.H51

51. Borlaug BA, Melenovsky V, Redfield MM, Kessler K, Chang H-J, Abraham TP et al. Impact of Arterial Load and Loading Sequence on Left Ventricular Tissue Velocities in Humans. Journal of the American College of Cardiology. 2007;50(16):1570–7. DOI: 10.1016/j.jacc.2007.07.032

52. Chirinos JA, Segers P, Rietzschel ER, De Buyzere ML, Raja MW, Claessens T et al. Early and Late Systolic Wall Stress Differentially Relate to Myocardial Contraction and Relaxation in Middle-Aged Adults: The Asklepios Study. Hypertension. 2013;61(2):296–303. DOI: 10.1161/HYPERTENSIONAHA.111.00530

53. Gillebert TC, Leite-Moreira AF, De Hert SG. Relaxation–Systolic Pressure Relation: A Load-Independent Assessment of Left Ventricular Contractility. Circulation. 1997;95(3):745–52. DOI: 10.1161/01.CIR.95.3.745

54. Takimoto E, Soergel DG, Janssen PML, Stull LB, Kass DA, Murphy AM. Frequencyand Afterload-Dependent Cardiac Modulation In Vivo by Troponin I With Constitutively Active Protein Kinase A Phosphorylation Sites. Circulation Research. 2004;94(4):496–504. DOI: 10.1161/01.RES.0000117307.57798.F5

55. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hyper tension and diastolic dysfunction: a randomised trial. The Lancet. 2007;369(9579):2079–87. DOI: 10.1016/S0140-6736(07)60980-5

56. Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan R-S et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. European Heart Journal. 2018;39(37):3439–50. DOI: 10.1093/eurheartj/ehy531

57. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology. 2013;62(4):263–71. DOI: 10.1016/j.jacc.2013.02.092

58. Rider OJ, Francis JM, Ali MK, Holloway C, Pegg T, Robson MD et al. Effects of Catecholamine Stress on Diastolic Function and Myocardial Energetics in Obesity. Circulation. 2012;125(12):1511–9. DOI: 10.1161/CIRCULATIONAHA.111.069518

59. Kozakova M, Fraser AG, Buralli S, Magagna A, Salvetti A, Ferrannini E et al. Reduced Left Ventricular Functional Reserve in Hypertensive Patients with Preserved Function at Rest. Hypertension. 2005;45(4):619–24. DOI: 10.1161/01.HYP.0000158838.34131.30

60. Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM. Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction. Circulation. 2015;131(6):550–9. DOI: 10.1161/CIRCULATIONAHA.114.009625

61. Gan L-M, Wikstrom J, Fritsche-Danielson R. Coronary Flow Reserve from Mouse to Man—from Mechanistic Understanding to Future Interventions. Journal of Cardiovascular Translational Research. 2013;6(5):715–28. DOI: 10.1007/s12265-013-9497-5

62. Rowell LB. Human cardiovascular control. -New York: Oxford University Press; 500 p. ISBN 978-0-19-507362-1

63. Middlekauff HR. Making the Case for Skeletal Myopathy as the Major Limitation of Exercise Capacity in Heart Failure. Circulation: Heart Failure. 2010;3(4):537–46. DOI: 10.1161/CIRCHEARTFAILURE.109.903773

64. Dhakal BP, Malhotra R, Murphy RM, Pappagianopoulos PP, Baggish AL, Weiner RB et al. Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction: The Role of Abnormal Peripheral Oxygen Extraction. Circulation: Heart Failure. 2015;8(2):286–94. DOI: 10.1161/CIRCHEARTFAILURE.114.001825

65. Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, AdamsHuet B et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. European Journal of Heart Failure. 2011;13(12):1296–304. DOI: 10.1093/eurjhf/hfr133

66. Haykowsky MJ, Kouba EJ, Brubaker PH, Nicklas BJ, Eggebeen J, Kitzman DW. Skeletal Muscle Composition and Its Relation to Exercise Intolerance in Older Patients with Heart Failure and Preserved Ejection Fraction. The American Journal of Cardiology. 2014;113(7):1211–6. DOI: 10.1016/j.amjcard.2013.12.031

67. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of Exercise Intolerance in Elderly Heart Failure Patients with Preserved Ejection Fraction. Journal of the American College of Cardiology. 2011;58(3):265–74. DOI: 10.1016/j.jacc.2011.02.055

68. Haykowsky MJ, Brubaker PH, Morgan TM, Kritchevsky S, Eggebeen J, Kitzman DW. Impaired Aerobic Capacity and Physical Functional Performance in Older Heart Failure Patients with Preserved Ejection Fraction: Role of Lean Body Mass. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2013;68(8):968–75. DOI: 10.1093/gerona/glt011

69. Leite-Moreira AF, Lourenco AP, Roncon-Albuquerque R, HenriquesCoelho T, Amorim MJ, Almeida J et al. Diastolic tolerance to systolic pressures closely reflects systolic performance in patients with coronary heart disease. Basic Research in Cardiology. 2012;107(2):251. DOI: 10.1007/s00395-012-0251-y

70. Heinonen I, Bucci M, Kemppainen J, Knuuti J, Nuutila P, Boushel R et al. Regulation of subcutaneous adipose tissue blood flow during exercise in humans. Journal of Applied Physiology. 2012;112(6):1059–63. DOI: 10.1152/japplphysiol.00732.2011

71. Kitzman DW, Nicklas B, Kraus WE, Lyles MF, Eggebeen J, Morgan TM et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. American Journal of Physiology-Heart and Circulatory Physiology. 2014;306(9):H1364–70. DOI: 10.1152/ajpheart.00004.2014

72. Molina AJA, Bharadwaj MS, Van Horn C, Nicklas BJ, Lyles MF, Eggebeen J et al. Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients with Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance. JACC: Heart Failure. 2016;4(8):636–45. DOI: 10.1016/j.jchf.2016.03.011

73. Bowen TS, Rolim NPL, Fischer T, Baekkerud FH, Medeiros A, Werner S et al. Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle: Skeletal muscle dysfunction in HFpEF. European Journal of Heart Failure. 2015;17(3):263–72. DOI: 10.1002/ejhf.239

74. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. Journal of the American College of Cardiology. 2012;59(11):998–1005. DOI: 10.1016/j.jacc.2011.11.040

75. Kitzman DW, Haykowsky MJ. Invited editorial commentary for American Heart Journal mechanisms of exercise training in heart failure with preserved ejection fraction: Central disappointment and peripheral promise. American Heart Journal. 2012;164(6):807–9. DOI: 10.1016/j.ahj.2012.09.002

76. Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise Training in Older Patients with Heart Failure and Preserved Ejection Fraction: A Randomized, Controlled, Single-Blind Trial. Circulation: Heart Failure. 2010;3(6):659–67. DOI: 10.1161/CIRCHEARTFAILURE.110.958785

77. Edelmann F, Gelbrich G, Dungen H-D, Frohling S, Wachter R, Stahrenberg R et al. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology. 2011;58(17):1780–91. DOI: 10.1016/j.jacc.2011.06.054

78. Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J, Kitzman D et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circulation. Heart Failure. 2015;8(1):33–40. DOI: 10.1161/CIRCHEARTFAILURE.114.001615

79. Haykowsky MJ, Brubaker PH, Stewart KP, Morgan TM, Eggebeen J, Kitzman DW. Effect of Endurance Training on the Determinants of Peak Exercise Oxygen Consumption in Elderly Patients with Stable Compensated Heart Failure and Preserved Ejection Fraction. Journal of the American College of Cardiology. 2012;60(2):120–8. DOI: 10.1016/j.jacc.2012.02.055

80. Edelmann F, Bobenko A, Gelbrich G, Hasenfuss G, Herrmann-Lingen C, Duvinage A et al. Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial: Exercise training in Diastolic Heart Failure (Ex-DHF). European Journal of Heart Failure. 2017;19(8):1067–74. DOI: 10.1002/ejhf.862

81. Willis MS, Patterson C. Proteotoxicity and Cardiac Dysfunction — Alzheimer’s Disease of the Heart? New England Journal of Medicine. 2013;368(5):455–64. DOI: 10.1056/NEJMra1106180

82. Shah SJ. Matchmaking for the Optimization of Clinical Trials of Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology. 2013;62(15):1339–42. DOI: 10.1016/j.jacc.2013.07.010